These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 32005282)

  • 1. Allogeneic human umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia in children: study protocol for a randomized controlled trial (MSC-BPD trial).
    Wu X; Xia Y; Zhou O; Song Y; Zhang X; Tian D; Li Q; Shu C; Liu E; Yuan X; He L; Liu C; Li J; Liang X; Yang K; Fu Z; Zou L; Bao L; Dai J
    Trials; 2020 Jan; 21(1):125. PubMed ID: 32005282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells for the prevention of bronchopulmonary dysplasia.
    Namba F
    Pediatr Int; 2019 Oct; 61(10):945-950. PubMed ID: 31487104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic administration of human umbilical cord-derived mesenchymal stem/stromal cells for bronchopulmonary dysplasia: preliminary outcomes in four Vietnamese infants.
    Nguyen LT; Trieu TTH; Bui HTH; Hoang VT; Nguyen ATT; Trinh NTH; Nguyen KT; Hoang DM
    J Transl Med; 2020 Oct; 18(1):398. PubMed ID: 33081796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6.
    Chaubey S; Thueson S; Ponnalagu D; Alam MA; Gheorghe CP; Aghai Z; Singh H; Bhandari V
    Stem Cell Res Ther; 2018 Jun; 9(1):173. PubMed ID: 29941022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial.
    Chang YS; Ahn SY; Yoo HS; Sung SI; Choi SJ; Oh WI; Park WS
    J Pediatr; 2014 May; 164(5):966-972.e6. PubMed ID: 24508444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of human umbilical cord-derived mesenchymal stem cells for treatment of severe bronchopulmonary dysplasia.
    Xia Y; Lang T; Niu Y; Wu X; Zhou O; Dai J; Bao L; Yang K; Zou L; Fu Z; Geng G
    Genes Dis; 2023 Mar; 10(2):521-530. PubMed ID: 37223507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated intravenous doses of human umbilical cord-derived mesenchymal stromal cells for bronchopulmonary dysplasia: results of a phase 1 clinical trial with 2-year follow-up.
    Cerro Marín MJD; Ormazábal IG; Gimeno-Navarro A; Álvarez-Fuente M; López-Ortego P; Avila-Alvarez A; Arruza Gómez L; González-Menchen C; Labrandero de Lera C; Lozano Balseiro M; Moreno Gutiérrez L; Melen Frajilich G; Ramírez Orellana M; Saldaña García N; Pavón Delgado A; Vento Torres M;
    Cytotherapy; 2024 Jun; 26(6):632-640. PubMed ID: 38556960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal delivery of human umbilical cord Wharton's jelly mesenchymal stromal cells restores lung alveolarization and vascularization in experimental bronchopulmonary dysplasia.
    Moreira A; Winter C; Joy J; Winter L; Jones M; Noronha M; Porter M; Quim K; Corral A; Alayli Y; Seno T; Mustafa S; Hornsby P; Ahuja S
    Stem Cells Transl Med; 2020 Feb; 9(2):221-234. PubMed ID: 31774626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effects of Bone Marrow-derived Versus Umbilical Cord Tissue Mesenchymal Stem Cells in an Experimental Model of Bronchopulmonary Dysplasia.
    Benny M; Courchia B; Shrager S; Sharma M; Chen P; Duara J; Valasaki K; Bellio MA; Damianos A; Huang J; Zambrano R; Schmidt A; Wu S; Velazquez OC; Hare JM; Khan A; Young KC
    Stem Cells Transl Med; 2022 Mar; 11(2):189-199. PubMed ID: 35298658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cells for bronchopulmonary dysplasia in preterm infants: A randomized controlled phase II trial.
    Ahn SY; Chang YS; Lee MH; Sung SI; Lee BS; Kim KS; Kim AR; Park WS
    Stem Cells Transl Med; 2021 Aug; 10(8):1129-1137. PubMed ID: 33876883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Off-label mesenchymal stromal cell treatment in two infants with severe bronchopulmonary dysplasia: clinical course and biomarkers profile.
    Álvarez-Fuente M; Arruza L; Lopez-Ortego P; Moreno L; Ramírez-Orellana M; Labrandero C; González Á; Melen G; Cerro MJD
    Cytotherapy; 2018 Nov; 20(11):1337-1344. PubMed ID: 30327248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of Intratracheal Administration of Human Umbilical Cord Blood Derived Mesenchymal Stromal Cells in Extremely Low Birth Weight Preterm Infants.
    Powell SB; Silvestri JM
    J Pediatr; 2019 Jul; 210():209-213.e2. PubMed ID: 30992220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human amnion cells for the prevention of bronchopulmonary dysplasia: a protocol for a phase I dose escalation study.
    Baker EK; Malhotra A; Lim R; Jacobs SE; Hooper SB; Davis PG; Wallace EM
    BMJ Open; 2019 Mar; 9(2):e026265. PubMed ID: 30826799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of umbilical cord tissue-derived mesenchymal stem cells in the treatment of patients with aging frailty: a phase I/II randomized, double-blind, placebo-controlled study.
    Zhu Y; Huang C; Zheng L; Li Q; Ge J; Geng S; Zhai M; Chen X; Yuan H; Li Y; Jia W; Sun K; Li Y; Ye T; Zhao Z; Liu H; Liu Z; Jiang H
    Stem Cell Res Ther; 2024 Apr; 15(1):122. PubMed ID: 38679727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Alleviate Lung Injury in Rat Model of Bronchopulmonary Dysplasia by Affecting Cell Survival and Angiogenesis.
    You J; Zhou O; Liu J; Zou W; Zhang L; Tian D; Dai J; Luo Z; Liu E; Fu Z; Zou L
    Stem Cells Dev; 2020 Dec; 29(23):1520-1532. PubMed ID: 33040709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consecutive daily administration of intratracheal surfactant and human umbilical cord-derived mesenchymal stem cells attenuates hyperoxia-induced lung injury in neonatal rats.
    Chou HC; Chang CH; Chen CH; Lin W; Chen CM
    Stem Cell Res Ther; 2021 May; 12(1):258. PubMed ID: 33933128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Umbilical Cord Mesenchymal Stem Cells to Treat Neuromyelitis Optica Spectrum Disorder (hUC-MSC-NMOSD): A Study Protocol for a Prospective, Multicenter, Randomized, Placebo-Controlled Clinical Trial.
    Yao XY; Xie L; Cai Y; Zhang Y; Deng Y; Gao MC; Wang YS; Xu HM; Ding J; Wu YF; Zhao N; Wang Z; Song YY; Wang LP; Xie C; Li ZZ; Wan WB; Lin Y; Jin HF; Wang K; Qiu HY; Zhuang L; Zhou Y; Jin YY; Ni LP; Yan JL; Guo Q; Xue JH; Qian BY; Guan YT
    Front Neurol; 2022; 13():860083. PubMed ID: 35547390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic evidence of umbilical cord-derived mesenchymal stem cell transplantation for cerebral palsy: a randomized, controlled trial.
    Gu J; Huang L; Zhang C; Wang Y; Zhang R; Tu Z; Wang H; Zhou X; Xiao Z; Liu Z; Hu X; Ke Z; Wang D; Liu L
    Stem Cell Res Ther; 2020 Feb; 11(1):43. PubMed ID: 32014055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Umbilical Cord Mesenchymal Stromal Cell Transplantation in Myocardial Ischemia (HUC-HEART Trial). A Study Protocol of a Phase 1/2, Controlled and Randomized Trial in Combination with Coronary Artery Bypass Grafting.
    Can A; Ulus AT; Cinar O; Topal Celikkan F; Simsek E; Akyol M; Canpolat U; Erturk M; Kara F; Ilhan O
    Stem Cell Rev Rep; 2015 Oct; 11(5):752-60. PubMed ID: 26123356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of human umbilical cord-derived mesenchymal stem cells (hUC-MSC PLEB001) for the treatment of grade II-IV steroid-refractory acute graft-versus-host disease: a study protocol for a multicenter, randomized, double-blind, placebo-controlled, phase II trial.
    Yang D; Hou X; Qian K; Li Y; Hu L; Li L; Han M; Yao C; Liu D
    Trials; 2023 May; 24(1):306. PubMed ID: 37138332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.